Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 05/05 08:16:37 pm
71.372 EUR   +1.77%
07:38pDJREGENERON PHARM : Raises Sales Expectations for Eylea -- Update
06:54p SANOFI : presses drugmaker Medivation to take $9.3B offer
05:36pDJSANOFI : Will Try to Oust Medivation Board Unless Deal Talks Start
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

SANOFI : PRESS RELEASE : Former Research Chemist At Global Pharmaceutical Company Sentenced To 18 Months In Prison For Theft Of Trade Secrets

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/07/2012 | 07:17pm CEST

United States Attorney

District of New Jersey

FOR IMMEDIATE RELEASE CONTACT: Rebekah Carmichael

May 7, 2012 Office of Public Affairs

www.justice.gov/usao/nj (973) 645-2888

FORMER RESEARCH CHEMIST AT GLOBAL PHARMACEUTICAL COMPANY

SENTENCED TO 18 MONTHS IN PRISON FOR THEFT OF TRADE SECRETS

TRENTON, N.J. - A former research chemist with global pharmaceutical company

sanofi-aventis ("sanofi") was sentenced today to 18 months in prison for stealing sanofi's trade

secrets and making them available for sale through Abby Pharmatech, Inc. ("Abby"), the U.S.

subsidiary of a Chinese chemicals company, U.S. Attorney Paul J. Fishman announced.

Yuan Li, 30, of Somerset, N.J., a Chinese national, previously pleaded guilty to an

Information charging her with one count of theft of trade secrets. Li entered her guilty plea

before U.S. District Judge Joel A. Pisano, who also imposed the sentence today in Trenton

federal court.

According to documents filed in this case and statements made in court:

Sanofi is a global healthcare company with U.S. headquarters in Bridgewater, N.J.

Among other things, sanofi is engaged in the development, manufacture and marketing of

healthcare products including the prescription drugs Allegra, Plavix, Copaxone and Ambien.

Li worked as a research scientist at sanofi's Bridgewater headquarters from October 2006

through June 2011, where she directly assisted in the development of a number of compounds

that sanofi viewed as potential building blocks for future drugs. These compounds were sanofi's

trade secrets and had not been disclosed outside of sanofi in any manner, including by means of a

patent application.

While employed at sanofi, Li was also a 50 percent partner in Abby, which is engaged in

the sale and distribution of pharmaceuticals.

Li admitted that between January 2010 and June 2011, she accessed an internal sanofi

database and downloaded information related to a number of sanofi compounds, including their

chemical structures, onto her sanofi-issued laptop computer. She also admitted she then

transferred the information to her personal home computer by sending it to her personal e-mail

address or via a USB thumb drive.

Li acknowledged that she made the stolen compounds available for sale on Abby's

website.

In addition to the prison term, Judge Pisano sentenced Li to serve two years of supervised

release and ordered her to pay $131,000 in restitution.

U.S. Attorney Fishman credited special agents of the FBI, under the direction of Special

Agent in Charge Michael B. Ward, with the investigation.

The government is represented by Assistant U.S. Attorney Gurbir S. Grewal of the

Computer Hacking and Intellectual Property Section of the U.S. Attorney's Office Economic

Crimes Unit in Newark.

12-159 ###

Defense counsel: Paul Brickfield Esq., River Edge, N.J.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on SANOFI
07:38pDJREGENERON PHARMACEUTICALS : Raises Sales Expectations for Eylea -- Update
07:16p SANOFI : US Collaborates with Duke University and Massachusetts General Hospital..
06:54p SANOFI : presses drugmaker Medivation to take $9.3B offer
05:36pDJSANOFI : Will Try to Oust Medivation Board Unless Deal Talks Start
05:24pDJSanofi Says It Will Try to Oust Medivation Board Members if Deal Talks Don't ..
03:45p Sanofi ready to raise Medivation offer, could oust board
02:25p SANOFI : Sends Letter to Medivation's Board of Directors
02:16pDJRegeneron Raises Sales Expectations for Eylea
02:04pDJREGENERON PHARMACEUTICALS : Raises Sales Expectations for Eylea
05/04 Sanofi sees 'strong strategic' fit with U.S. Medivation
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials